Skip to main content

Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics was previously published as Anti-Cancer Drug Design.

Publisher: Cognizant Communication Corporation

Volume 12, Number 3, 2001

Research Articles

Structure–Activity Studies of Novobiocin Analogs as Modulators of the Cytotoxicity of Etoposide (VP-16)
pp. 113-119(7)
Authors: Rappa, G.; Shyam, K.; Lorico, A.; Fodstad Ø.; Sartorelli, A.C.

Favourites:
ADD

Induction of Hepatocellular Carcinoma With High Metastatic Potential in WS/Shi Rats: Discovery of an Inbred Strain Highly Susceptible to the Liver Carcinogen N-Nitrosomorpholine
pp. 121-126(6)
Authors: Murai, T.; Mori, S.; Hosono, M.; Iwakura, Y.; Takashima, A.; Oohara, T.; Makino, S.; Takeda, R.; Fukushima, S.

Favourites:
ADD

Tumor Amplified Protein Expression Therapy: Salmonella as a Tumor-Selective Protein Delivery Vector
pp. 127-135(9)
Authors: Zheng, L-m.; Luo, X.; Feng, M.; Li, Z.; Le, T.; Ittensohn, M.; Trailsmith, M.; Bermudes, D.; Lin, S.L.; King, I.C.

Favourites:
ADD

Schedule-Dependent Interaction Between Raltitrexed and 5-Fluorouracil in Human Colon Cancer Cell Lines In Vitro
pp. 137-148(12)
Authors: Kano, Y.; Akutsu, M.; Suzuki, K.; Yazawa, Y.; Tsunoda, S.; Furukawa, Y.

Favourites:
ADD

Radiation-Induced Cell Cycle Delays and p53 Status of Early Passage Melanoma Cell Lines
pp. 149-155(7)
Authors: Parmar, J.; Marshall, E.S.; Charters, G.A.; Holdaway, K.M.; Shelling, A.N.; Baguley, B.C.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more